Cargando…
Is a COVID-19 vaccine developed by nature already at work?
The COVID-19 positive cases are increasing at an alarming rate across the world. On the contrary, the morbidity and mortality are showing decreasing trend as time progresses. The most intriguing part is the rise in asymptomatic Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) positive c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538374/ https://www.ncbi.nlm.nih.gov/pubmed/33059225 http://dx.doi.org/10.1016/j.mehy.2020.110335 |
_version_ | 1783590856864825344 |
---|---|
author | Sharma, Nilesh Kumar Sarode, Sachin C. Sarode, Gargi Patil, Shankargouda |
author_facet | Sharma, Nilesh Kumar Sarode, Sachin C. Sarode, Gargi Patil, Shankargouda |
author_sort | Sharma, Nilesh Kumar |
collection | PubMed |
description | The COVID-19 positive cases are increasing at an alarming rate across the world. On the contrary, the morbidity and mortality are showing decreasing trend as time progresses. The most intriguing part is the rise in asymptomatic Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) positive cases in the population, which made us speculate some kind of gradual development of immunity in the population. To date, no attention has been given to the accumulation of killed/inactivated/degenerated SARS-CoV-2 associated molecular particle patterns (SAMPPs). In this paper, we introduced the concept of SAMMPs and its existence on inanimate objects is quite conceivable due to the size of SARS-CoV-2 and exuberant shedding of the virus in respiratory secretions. SAMPPs can come into the contact with mucosal surfaces and thereof associated antigen-presenting dendritic cells. Thus, we hypothesized the existence of SAMPPs mediated the development of immunity against SARS-CoV-2 infection, which has caused an increase in the incidence rate of asymptomatic cases and a decrease in mortality rate. To understand the existence of SAMPPs associated natural immunity against SARS-CoV-2, future population based serological testing are recommended to investigate serum antibody levels against various molecular particles associated with SAMPPs. |
format | Online Article Text |
id | pubmed-7538374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75383742020-10-07 Is a COVID-19 vaccine developed by nature already at work? Sharma, Nilesh Kumar Sarode, Sachin C. Sarode, Gargi Patil, Shankargouda Med Hypotheses Article The COVID-19 positive cases are increasing at an alarming rate across the world. On the contrary, the morbidity and mortality are showing decreasing trend as time progresses. The most intriguing part is the rise in asymptomatic Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) positive cases in the population, which made us speculate some kind of gradual development of immunity in the population. To date, no attention has been given to the accumulation of killed/inactivated/degenerated SARS-CoV-2 associated molecular particle patterns (SAMPPs). In this paper, we introduced the concept of SAMMPs and its existence on inanimate objects is quite conceivable due to the size of SARS-CoV-2 and exuberant shedding of the virus in respiratory secretions. SAMPPs can come into the contact with mucosal surfaces and thereof associated antigen-presenting dendritic cells. Thus, we hypothesized the existence of SAMPPs mediated the development of immunity against SARS-CoV-2 infection, which has caused an increase in the incidence rate of asymptomatic cases and a decrease in mortality rate. To understand the existence of SAMPPs associated natural immunity against SARS-CoV-2, future population based serological testing are recommended to investigate serum antibody levels against various molecular particles associated with SAMPPs. Elsevier Ltd. 2020-12 2020-10-07 /pmc/articles/PMC7538374/ /pubmed/33059225 http://dx.doi.org/10.1016/j.mehy.2020.110335 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sharma, Nilesh Kumar Sarode, Sachin C. Sarode, Gargi Patil, Shankargouda Is a COVID-19 vaccine developed by nature already at work? |
title | Is a COVID-19 vaccine developed by nature already at work? |
title_full | Is a COVID-19 vaccine developed by nature already at work? |
title_fullStr | Is a COVID-19 vaccine developed by nature already at work? |
title_full_unstemmed | Is a COVID-19 vaccine developed by nature already at work? |
title_short | Is a COVID-19 vaccine developed by nature already at work? |
title_sort | is a covid-19 vaccine developed by nature already at work? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538374/ https://www.ncbi.nlm.nih.gov/pubmed/33059225 http://dx.doi.org/10.1016/j.mehy.2020.110335 |
work_keys_str_mv | AT sharmanileshkumar isacovid19vaccinedevelopedbynaturealreadyatwork AT sarodesachinc isacovid19vaccinedevelopedbynaturealreadyatwork AT sarodegargi isacovid19vaccinedevelopedbynaturealreadyatwork AT patilshankargouda isacovid19vaccinedevelopedbynaturealreadyatwork |